These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mutant-selective thyromimetics for the chemical rescue of thyroid hormone receptor mutants associated with resistance to thyroid hormone. Shi Y; Ye H; Link KH; Putnam MC; Hubner I; Dowdell S; Koh JT Biochemistry; 2005 Mar; 44(12):4612-26. PubMed ID: 15779888 [TBL] [Abstract][Full Text] [Related]
5. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design. Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255 [TBL] [Abstract][Full Text] [Related]
6. Structure-based design and synthesis of a thyroid hormone receptor (TR) antagonist. Baxter JD; Goede P; Apriletti JW; West BL; Feng W; Mellstrom K; Fletterick RJ; Wagner RL; Kushner PJ; Ribeiro RC; Webb P; Scanlan TS; Nilsson S Endocrinology; 2002 Feb; 143(2):517-24. PubMed ID: 11796506 [TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. Meyers MJ; Sun J; Carlson KE; Marriner GA; Katzenellenbogen BS; Katzenellenbogen JA J Med Chem; 2001 Nov; 44(24):4230-51. PubMed ID: 11708925 [TBL] [Abstract][Full Text] [Related]
8. Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity. Malm J; Gordon S; Brandt P; Carlsson B; Agback P; Bäckbro Saeidi A; Sandberg J Bioorg Med Chem Lett; 2007 Apr; 17(7):2018-21. PubMed ID: 17254783 [TBL] [Abstract][Full Text] [Related]
17. Analogues of oxytocin antagonists bearing a ureido group in the amino acid side chain at position 4 or 5. Flouret G; Chaloin O; Borovickova L; Slaninová J J Pept Sci; 2006 May; 12(5):347-53. PubMed ID: 16285023 [TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal progesterone receptor ligands (I): synthesis and SAR of new tetrahydronaphthofuranone derivatives. Shinei R; Kurihara K; Tanabe K; Tabata Y; Kurata Y; Hoshiko S; Okonogi T Bioorg Med Chem; 2006 Jul; 14(14):4850-61. PubMed ID: 16580213 [TBL] [Abstract][Full Text] [Related]
19. 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists. Zlotos DP; Attia MI; Julius J; Sethi S; Witt-Enderby PA J Med Chem; 2009 Feb; 52(3):826-33. PubMed ID: 19193160 [TBL] [Abstract][Full Text] [Related]
20. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban. Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]